![](/img/cover-not-exists.png)
359O_PR Efficacy and safety of pembrolizumab (MK-3475) in recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC): Subset analyses for Asia-pacific patients in KEYNOTE-012 (KN-012) B2 cohort
Tahara, M., Muro, K., Hasegawa, Y., Chung, H.C., Lin, C-C., Keam, B., Cheng, J., Bang, Y-J.Volume:
27
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw587.001
Date:
December, 2016
File:
PDF, 43 KB
english, 2016